K

Kindstar Globalgene Technology Inc
HKEX:9960

Watchlist Manager
Kindstar Globalgene Technology Inc
HKEX:9960
Watchlist
Price: 1.58 HKD 1.94% Market Closed
Updated: May 27, 2024

Profitability Summary

Kindstar Globalgene Technology Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Kindstar Globalgene Technology Inc

Revenue
967.3m CNY
Cost of Revenue
-517.2m CNY
Gross Profit
450m CNY
Operating Expenses
-518.1m CNY
Operating Income
-68.1m CNY
Other Expenses
109.4m CNY
Net Income
41.3m CNY

Margins Comparison
Kindstar Globalgene Technology Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Kindstar Globalgene Technology Inc
HKEX:9960
1.5B HKD
47%
-7%
4%
US
Cigna Group
XMUN:CGN
87.5B EUR
12%
5%
2%
US
Cigna Corp
NYSE:CI
94.5B USD
12%
5%
2%
US
CVS Health Corp
NYSE:CVS
69.5B USD
15%
4%
2%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.4B EUR
23%
6%
-1%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.8B USD
28%
9%
4%
US
Quest Diagnostics Inc
NYSE:DGX
15.7B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR
25%
7%
2%
US
DaVita Inc
NYSE:DVA
12.2B USD
32%
14%
7%
DE
Fresenius Medical Care AG
XMUN:FME
11.1B EUR
25%
7%
2%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
-22%
-24%
Country CN
Market Cap 1.5B HKD
Gross Margin
47%
Operating Margin
-7%
Net Margin
4%
Country US
Market Cap 87.5B EUR
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 94.5B USD
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 69.5B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country DE
Market Cap 16.4B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-1%
Country US
Market Cap 16.8B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country US
Market Cap 15.7B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 11.4B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
2%
Country US
Market Cap 12.2B USD
Gross Margin
32%
Operating Margin
14%
Net Margin
7%
Country DE
Market Cap 11.1B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
2%
Country US
Market Cap 9.5B USD
Gross Margin
4%
Operating Margin
-22%
Net Margin
-24%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Kindstar Globalgene Technology Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Kindstar Globalgene Technology Inc
HKEX:9960
1.5B HKD
1%
1%
-2%
-4%
US
Cigna Group
XMUN:CGN
87.5B EUR
8%
2%
9%
7%
US
Cigna Corp
NYSE:CI
94.5B USD
8%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
69.5B USD
10%
3%
8%
6%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.4B EUR
-2%
-1%
4%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.8B USD
5%
2%
7%
4%
US
Quest Diagnostics Inc
NYSE:DGX
15.7B USD
13%
6%
11%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR
3%
1%
5%
3%
US
DaVita Inc
NYSE:DVA
12.2B USD
93%
5%
12%
9%
DE
Fresenius Medical Care AG
XMUN:FME
11.1B EUR
3%
1%
5%
3%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
Country CN
Market Cap 1.5B HKD
ROE
1%
ROA
1%
ROCE
-2%
ROIC
-4%
Country US
Market Cap 87.5B EUR
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 94.5B USD
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 69.5B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
6%
Country DE
Market Cap 16.4B EUR
ROE
-2%
ROA
-1%
ROCE
4%
ROIC
1%
Country US
Market Cap 16.8B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country US
Market Cap 15.7B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country DE
Market Cap 11.4B EUR
ROE
3%
ROA
1%
ROCE
5%
ROIC
3%
Country US
Market Cap 12.2B USD
ROE
93%
ROA
5%
ROCE
12%
ROIC
9%
Country DE
Market Cap 11.1B EUR
ROE
3%
ROA
1%
ROCE
5%
ROIC
3%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More